Early Results From Alzheimer's Neuroimaging Biomarker Project Show Promise For Faster Study Of Therapies
Alzheimer's disease researchers may be able to reduce the time and expense associated with clinical trials.
Preliminary results from ADNI show how it might yield improved methods and uniform standards for imaging and biomarker analysis, so these techniques can be employed in the fight against Alzheimer's disease.
These first findings will be presented at the Alzheimer's Association International Conference on the Prevention of Dementia being held in Washington, D.C., June 9-12.
The ADNI study observes and tracks changes in normal individuals, in people with mild cognitive impairment